Ocular Therapeutix Officer Files Intent to Sell $278k in Stock
OCULAR THERAPEUTIX, INC.
Subscribe to track OCUL
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Ocular Therapeutix Officer Files Intent to Sell $278k in Stock
Company: Ocular Therapeutix, Inc. (OCUL) Form: 144 | Filed: 2025-11-05 Significance: Low
Insider: NAMRATA SAROJ Title: Officer | Relationship: Officer
Transaction: • Type: Proposed Sale • Shares: 25,865 • Price: ~$10.74 • Value: $277,909 • Owned After: Not Disclosed
Key Insight: An officer has filed their intent to sell shares valued at approximately $278k. The transaction size is minor relative to the company's market cap and total shares outstanding.
Market Context: This proposed sale represents less than 0.02% of the company's shares outstanding and is considered a routine transaction with low market significance.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: Ocular Therapeutix, Inc. (OCUL)
Executive Summary
- Trading Significance: Low
- Key Takeaway: An officer of Ocular Therapeutix has filed a notice of intent to sell approximately $278k worth of common stock.
- Market Impact: The transaction is of low materiality and is unlikely to have a significant impact on the stock.
Company Information
| Field | Value |
|---|---|
| Company | OCULAR THERAPEUTIX, INC. |
| Ticker Symbol | OCUL |
| CIK | 0001393434 |
| Industry | PHARMACEUTICAL PREPARATIONS |
Insider Information
| Field | Value |
|---|---|
| Name | NAMRATA SAROJ |
| CIK | 0002073624 |
| Title/Position | Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 144 |
| Transaction Date | 2025-11-05 |
| Transaction Code | S |
| Security Type | Common Stock |
| Shares Involved | 25,865 |
| Price Per Share | $10.74 |
| Total Value | $277,909.08 |
| Shares Owned After | Not Disclosed |
| Ownership Type | Not Disclosed |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $277,909.08 |
| % of Market Cap | 0.011% |
| Shares Transacted | 25,865 |
| % of Shares Outstanding | 0.015% |
| Post-Transaction Ownership | Not Disclosed |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The $278k sale is negligible compared to the company's $2.47 billion market capitalization.
- Transaction Significance: The sale represents a very small fraction of both the market cap and shares outstanding, indicating it is likely a routine financial management activity for the insider rather than a signal about the company's future prospects.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction size is too small (0.011% of market cap) to influence market sentiment or stock price.
Volume & Sentiment
- Expected Volume Impact: Minimal. The trade size is unlikely to be noticeable against the stock's average daily volume.
- Sentiment Indicator: Neutral. This filing is informational and does not suggest a change in the insider's outlook.
Additional Context
Transaction Notes
- This Form 144 filing is a notice of a proposed sale. The shares were originally acquired on November 4, 2025, through the vesting of restricted stock.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.